Showing results (931-940 of 2,292) with videos related to

Sort By:
Pageof 230
Clinical and Experimental Medicine|January 26, 2017
Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritisShichao Tong, Ji Liu, Changqing Zhang
Clinical and Experimental Medicine|April 29, 2015
Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammationYanhong Wang, Jihua Tian, Haixiu Guo, et al.
Clinical and Experimental Medicine|October 26, 2019
Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cellsMitsuki Tabata, Masanobu Tsubaki, Tomoya Takeda, et al.
Clinical and Experimental Medicine|May 25, 2015
CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemiaLidia Ciszak, Irena Frydecka, Dariusz Wolowiec, et al.
Clinical and Experimental Medicine|January 30, 2023
Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic LeukemiaMartina Quattrone, Alessia Di Pilla, Livio Pagano, et al.
Clinical and Experimental Medicine|April 24, 2015
Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancerMarcin Nicoś, Paweł Krawczyk, Bożena Jarosz, et al.
Clinical and Experimental Medicine|August 26, 2025
SLFN11, far from being limited to responding to cancer DNA damageHao Xiao, Zeping Han, Yingkai Tang, et al.
Clinical and Experimental Medicine|April 10, 2021
miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosisDaye Yang, Dewei Zhang
Clinical and Experimental Medicine|April 25, 2023
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodiesSalvatore Rotundo, Massimo Borelli, Vincenzo Scaglione, et al.
Clinical and Experimental Medicine|February 8, 2026
Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in NorwayMarius Stensland, Karina F Bru, Marie Austdal, et al.
Pageof 230